FDA advisory committee today is expected to scrutinize Moderna on vaccine reaction 

Sandra Lindsay, a critical care nurse at Long Island Jewish Medical Center, receives the first Pfizer-BioNTech vaccine in the U.S. on Dec. 14. (Photo courtesy Northwell Health.)
The FDA is recommending surveillance of Bell's palsy after four Moderna trial participants developed the temporary facial paralysis.

Read the full post on News Feed

smorse